Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cynthia Li
Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
BioDrugs
Medicine
Biotechnology
Pharmacology
Nomenclature and Semantic Descriptions of Ulcerative and Inflammatory Lesions Seen in Crohn’s Disease in Small Bowel Capsule Endoscopy: An International Delphi Consensus Statement
United European Gastroenterology Journal
Oncology
Gastroenterology
Related publications
A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
Advances in Therapy
Medicine
Pharmacology
Comparative Clinical Efficacy and Safety of the Proposed Biosimilar ABP 710 With Infliximab Reference Product in Patients With Rheumatoid Arthritis
Arthritis Research & Therapy
AB0954 a Randomised, Double-Blind Trial Comparing the Efficacy, Safety and Immunogenicity of Msb11022, a Proposed Biosimilar of Adalimumab, Versus Adalimumab Originator in Patients With Moderate-To-Severe Plaque Psoriasis
Physicochemical and Functional Characterization of a Biosimilar Adalimumab ZRC-3197
Biosimilars
A Budget Impact Analysis of Adalimumab Biosimilar: The Italian Context
AboutOpen
Case Study: Biosimilar Anti TNFalpha (Adalimumab) Analysis of Fc Effector Functions
BMC Proceedings
Biochemistry
Medicine
Genetics
Molecular Biology
Pharmacokinetic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology
Medicine
Hematology
Safety of Adalimumab Biosimilar MSB11022 (Acetate-Buffered Formulation) in Patients With Moderately-To-Severely Active Rheumatoid Arthritis
Clinical Rheumatology
Medicine
Rheumatology
Demonstrating Analytical Similarity of Trastuzumab Biosimilar HLX02 to Herceptin® With a Panel of Sensitive and Orthogonal Methods Including a Novel FcγRIIIa Affinity Chromatography Technology
BioDrugs
Medicine
Biotechnology
Pharmacology